$SBIG
springbig Holdings Inc Stock $sbig

$sbig Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023028887 Filed on August 10, 2023

Income Statement

Concept	2023 Q2	2022 Q2
Revenue	$7.214M	$6.584M
YoY Change	9.57%
Cost Of Revenue	$1.511M	$1.998M
YoY Change	-24.37%	6.84%
Gross Profit	$5.703M	$4.586M
YoY Change	24.36%	16.4%
Gross Profit Margin	79.05%	69.65%
Selling, General & Admin	$5.431M	$6.879M
YoY Change	-21.05%	92.15%
% of Gross Profit	95.23%	150.0%
Research & Development	$2.045M	$2.910M
YoY Change	-29.73%	60.77%
% of Gross Profit	35.86%	63.45%
Depreciation & Amortization	$64.00K	$123.0K
YoY Change	-47.97%
% of Gross Profit	1.12%	2.68%
Operating Expenses	$7.476M	$9.869M
YoY Change	-24.25%	5906.4%
Operating Profit	-$1.773M	-$5.283M
YoY Change	-66.44%	3115.3%
Interest Expense	-$320.0K	-$208.0K
YoY Change	53.85%	-1753.42%
% of Operating Profit
Other Income/Expense, Net	$60.00K	$2.880M
YoY Change	-97.92%	5.4%
Pretax Income	-$2.030M	-$2.611M
YoY Change	-22.25%	-201.66%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$2.028M	-$2.611M
YoY Change	-22.33%	-201.66%
Net Earnings / Revenue	-28.11%	-39.66%
Basic Earnings Per Share	-$0.06	-$0.14
Diluted Earnings Per Share	-$0.06	-$135.4K
COMMON SHARES
Basic Shares Outstanding	26.94M shares	19.29M shares
Diluted Shares Outstanding	31.49M shares	19.29M shares

Balance Sheet

Concept	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$730.0K	$14.18M
YoY Change	-94.85%	1694.81%
Cash & Equivalents	$700.0K	$14.18M
Short-Term Investments
Other Short-Term Assets	$1.570M	$2.742M
YoY Change	-42.74%	559.36%
Inventory
Prepaid Expenses
Receivables	$4.002M	$3.921M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$6.613M	$20.84M
YoY Change	-68.27%	1628.38%
LONG-TERM ASSETS
Property, Plant & Equipment	$328.0K	$471.0K
YoY Change	-30.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.223M	$721.0K
YoY Change	69.63%	-99.64%
TOTAL ASSETS
Total Short-Term Assets	$6.613M	$20.84M
Total Long-Term Assets	$1.223M	$721.0K
Total Assets	$7.836M	$21.56M
YoY Change	-63.66%	-89.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.467M	$3.532M
YoY Change	-30.15%	3274.41%
Accrued Expenses	$2.520M	$2.001M
YoY Change	25.94%	1752.78%
Deferred Revenue	$215.0K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.756M	$0.00
YoY Change
Total Short-Term Liabilities	$7.959M	$6.977M
YoY Change	14.07%	3180.64%
LONG-TERM LIABILITIES
Long-Term Debt	$2.830M	$9.843M
YoY Change	-71.25%
Other Long-Term Liabilities	$690.0K	$1.616M
YoY Change	-57.3%	-93.64%
Total Long-Term Liabilities	$3.520M	$11.46M
YoY Change	-69.28%	-54.89%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.959M	$6.977M
Total Long-Term Liabilities	$3.520M	$11.46M
Total Liabilities	$11.48M	$18.44M
YoY Change	-37.74%	-28.02%
SHAREHOLDERS EQUITY
Retained Earnings	-$30.60M
YoY Change
Common Stock	$4.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.643M	$3.127M
YoY Change
Total Liabilities & Shareholders Equity	$7.836M	$21.56M
YoY Change	-63.66%	-89.28%

Cashflow Statement

Concept	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	-$2.028M	-$2.611M
YoY Change	-22.33%	-201.66%
Depreciation, Depletion And Amortization	$64.00K	$123.0K
YoY Change	-47.97%
Cash From Operating Activities	-$2.940M	-$4.747M
YoY Change	-38.07%	19646.76%
INVESTING ACTIVITIES
Capital Expenditures	$70.00K	-$113.0K
YoY Change	-161.95%	-170.63%
Acquisitions
YoY Change
Other Investing Activities	-$10.00K	-$250.0K
YoY Change	-96.0%
Cash From Investing Activities	-$80.00K	-$363.0K
YoY Change	-77.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$82.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.170M	17.27M
YoY Change	-93.22%
NET CHANGE
Cash From Operating Activities	-2.940M	-4.747M
Cash From Investing Activities	-80.00K	-363.0K
Cash From Financing Activities	1.170M	17.27M
Net Change In Cash	-1.850M	12.16M
YoY Change	-115.22%	-50669.38%
FREE CASH FLOW
Cash From Operating Activities	-$2.940M	-$4.747M
Capital Expenditures	$70.00K	-$113.0K
Free Cash Flow	-$3.010M	-$4.634M
YoY Change	-35.05%	2418.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Cost Of Revenue CostOfRevenue	3520000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	4586000	usd
	us-gaap	Gross Profit GrossProfit	11510000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001801602
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	726000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3546000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4002000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2889000	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	312000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	333000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1573000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1505000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	6613000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8273000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	629000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	750000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375000	usd
CY2023Q2	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	266000	usd
CY2022Q4	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	259000	usd
CY2023Q2	us-gaap	Assets Assets	7836000	usd
CY2022Q4	us-gaap	Assets Assets	9657000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2467000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1056000	usd
CY2023Q2	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	1693000	usd
CY2022Q4	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	2554000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	1756000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	5451000	usd
CY2023Q2	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1442000	usd
CY2022Q4	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	0	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	215000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	386000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	465000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7959000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9817000	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2828000	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2814000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	316000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	338000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13285000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	312000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2891000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-89000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41402847	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41402847	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26659711	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26659711	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	4000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	3000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	26975000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	22701000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30622000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26332000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3643000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3628000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7836000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9657000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6454000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14371000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12627000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1868000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	2861000	usd
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6048000	usd
CY2022Q2	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	2910000	usd
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	4345000	usd
	us-gaap	Research And Development Expense Software Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost	5547000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3854000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6002000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5567000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	9868000	usd
	us-gaap	Operating Expenses OperatingExpenses	15011000	usd
	us-gaap	Operating Expenses OperatingExpenses	17162000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-5282000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3501000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8055000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	14000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2022Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	219000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	714000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2891000	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-2610000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-4290000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5476000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2610000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4290000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5476000	usd
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19285050	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29159766	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18586515	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18586515	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18586515	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18586515	shares
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-5615000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	205000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	161000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2384000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1250000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2028000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3643000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3628000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	367000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	274000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2384000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1250000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4290000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-3643000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1780000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1045000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	76000	usd
CY2022Q2	wdq	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	2836000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2610000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3127000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	4459000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1226000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	82000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2836000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5476000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3127000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4290000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5476000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	131000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	482000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	367000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1226000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	380000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	214000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-10000	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	0	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	121000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	0	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-89000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2891000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1493000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	766000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	68000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1815000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-21000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-40000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	471000	usd
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	4416000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-130000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	usd
	wdq	Increase Decrease In Social Security Tax Employer Deferral Cares Act IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct	-1442000	usd
	wdq	Increase Decrease In Social Security Tax Employer Deferral Cares Act IncreaseDecreaseInSocialSecurityTaxEmployerDeferralCARESAct	0	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-76000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-23000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2563000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4952000	usd
	wdq	Origination Of Notes Receivable OriginationOfNotesReceivable	6000	usd
	wdq	Origination Of Notes Receivable OriginationOfNotesReceivable	250000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	84000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	113000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-90000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-363000	usd
	wdq	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	usd
	wdq	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	10185000	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7000000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2913000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2661000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	189000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	274000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	82000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-167000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17267000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2820000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	11952000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3546000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2227000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	726000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	14179000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1250000	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	7305000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	4496000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	165000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	wdq	Cost Of Equity Issuance Deducted From Proceeds CostOfEquityIssuanceDeductedFromProceeds	342000	usd
	wdq	Cost Of Equity Issuance Deducted From Proceeds CostOfEquityIssuanceDeductedFromProceeds	0	usd
	wdq	Payments Of Accrued Stock Issuance Costs PaymentsOfAccruedStockIssuanceCosts	88000	usd
	wdq	Payments Of Accrued Stock Issuance Costs PaymentsOfAccruedStockIssuanceCosts	0	usd
	us-gaap	Interest Paid Net InterestPaidNet	248000	usd
	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q2	wdq	Number Of Subsidiaries NumberOfSubsidiaries	1	subsidiary
CY2022Q2	wdq	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.59289
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18800000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction Before Closing Costs ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts	25100000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7000000	usd
CY2022Q2	wdq	Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders	8800000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6100000	usd
CY2022Q2	wdq	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	8700000	usd
CY2022Q2	wdq	Reverse Recapitalization Net ReverseRecapitalizationNet	10100000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-30600000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2600000	usd
CY2023Q2	wdq	Working Capital WorkingCapital	-1300000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	700000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Use of Estimates</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions that we believe to be reasonable. We believe that the assumptions and estimates associated with </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">revenue recognition, software development costs, income taxes, and equity-based compensation have the greatest potential impact on our consolidated financial statements. Therefore, we consider these to be our critical accounting policies and estimates. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Future events and their effects cannot be predicted with certainty; accordingly, accounting estimates require the exercise of judgment. Accounting estimates used in the preparation of these financial statements change as new events occur, as more experience is acquired, as additional information is obtained, and as the operating environment changes. Actual results may differ materially from these estimates.</span></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%;text-decoration:underline">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"> </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Financial instruments that potentially subject us to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable. We place our cash and cash equivalents with high credit-quality financial institutions. Such deposits may be in excess of federally insured limits. To date, we have not experienced any losses on our cash and cash equivalents. We perform periodic evaluations of the relative credit standing of the financial institutions. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We perform ongoing credit evaluations of our customers’ financial condition and require no collateral from our customers. We maintain an credit loss reserve for doubtful accounts The evaluation of expected losses is based on the probability of default using historical loss rates, as well as adjustments for forward-looking information, including industry and macroeconomic forecasts, as required.receivable based upon the expected collectability of accounts receivable balances. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Effective Accounting Pronouncements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> within this Note below for further information.</span></div>
CY2023Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	500000	usd
CY2023Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	4980000	usd
CY2022Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	3639000	usd
CY2023Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	883000	usd
CY2022Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	731000	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5863000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	4370000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1861000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1481000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4002000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2889000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2023Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	400000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	usd
CY2023Q2	us-gaap	Prepaid Insurance PrepaidInsurance	829000	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	834000	usd
CY2023Q2	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	645000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	582000	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	99000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	89000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1573000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1505000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	915000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	831000	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	587000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	456000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	328000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	375000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P3Y
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	123000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	64000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	131000	usd
CY2022Q2	us-gaap	Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss Noncurrent FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLossNoncurrent	250000	usd
CY2022Q2	wdq	Financing Receivable Before Allowance For Credit Loss Noncurrent Interest Rate FinancingReceivableBeforeAllowanceForCreditLossNoncurrentInterestRate	0.05
CY2023Q2	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	3000	usd
	us-gaap	Interest Income Financing Receivable Before Allowance For Credit Loss InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss	6000	usd
CY2023Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	200000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1145000	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	358000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	148000	usd
CY2023Q2	wdq	Deferred Financial Advisory Fees Current DeferredFinancialAdvisoryFeesCurrent	1000000	usd
CY2022Q4	wdq	Deferred Financial Advisory Fees Current DeferredFinancialAdvisoryFeesCurrent	1006000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	135000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	255000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	651000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	781000	usd
CY2023Q2	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	1693000	usd
CY2022Q4	wdq	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	2554000	usd
CY2022Q2	wdq	Reverse Recapitalization Cash Paid To Shareholders ReverseRecapitalizationCashPaidToShareholders	191437817	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18800000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction Before Closing Costs ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts	25100000	usd
CY2022Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	7000000	usd
CY2022Q2	wdq	Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders	8800000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6100000	usd
CY2022Q2	wdq	Cash Acquired Through Reverse Recapitalization After Payment To Redeeming Stockholders CashAcquiredThroughReverseRecapitalizationAfterPaymentToRedeemingStockholders	8771000	usd
CY2022Q2	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6100000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Operating Account ProceedsFromReverseRecapitalizationOperatingAccount	264000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction Before Closing Costs ProceedsFromReverseRecapitalizationTransactionBeforeClosingCosts	25135000	usd
CY2022Q2	wdq	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	6346000	usd
CY2022Q2	wdq	Proceeds From Reverse Recapitalization Transaction ProceedsFromReverseRecapitalizationTransaction	18789000	usd
CY2022Q2	wdq	Reverse Recapitalization Accrued Transaction Costs ReverseRecapitalizationAccruedTransactionCosts	8679000	usd
CY2022Q2	wdq	Reverse Recapitalization Net ReverseRecapitalizationNet	10110000	usd
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25290270	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25290270	shares
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	323000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	714000	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	64000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-89000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	226000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	253000	usd
CY2023Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	93000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6454000	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	1868000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	3520000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	4586000	usd
	us-gaap	Gross Profit GrossProfit	9107000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7214000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6454000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12627000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7214000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6454000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14371000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12627000	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	312000	usd
CY2022Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	333000	usd
CY2022Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	333000	usd
CY2021Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	364000	usd
	wdq	Contract With Customer Assets Expense Deferred Including Opening Balance ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance	94000	usd
CY2022	wdq	Contract With Customer Assets Expense Deferred Including Opening Balance ContractWithCustomerAssetsExpenseDeferredIncludingOpeningBalance	176000	usd
	wdq	Contract With Customer Assets Amounts Expensed During The Year ContractWithCustomerAssetsAmountsExpensedDuringTheYear	115000	usd
CY2022	wdq	Contract With Customer Assets Amounts Expensed During The Year ContractWithCustomerAssetsAmountsExpensedDuringTheYear	207000	usd
CY2023Q2	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	312000	usd
CY2022Q4	wdq	Contract With Customer Assets Current ContractWithCustomerAssetsCurrent	333000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	215000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	450000	usd
	wdq	Contract With Customer Liability Amounts Invoiced During The Year ContractWithCustomerLiabilityAmountsInvoicedDuringTheYear	10060000	usd
CY2022	wdq	Contract With Customer Liability Amounts Invoiced During The Year ContractWithCustomerLiabilityAmountsInvoicedDuringTheYear	18310000	usd
	wdq	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	10136000	usd
CY2022	wdq	Contract With Customer Liability Revenue Recognized Including Opening Balance ContractWithCustomerLiabilityRevenueRecognizedIncludingOpeningBalance	18469000	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	215000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	291000	usd
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	129000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3394753	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.57
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3250236	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y9M14D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.54
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	727233	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.38
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	25876	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.82
	wdq	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriod	0	shares
	wdq	Share Based Compensation Arrangements By Share Based Payment Award Options Cancelled In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCancelledInPeriodWeightedAverageExercisePrice	0
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2641644	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.62
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2545299	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y2M19D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	162000	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2545299	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	290000	usd
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	122000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P98M
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	629000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	750000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	386000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	465000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	265000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	316000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	226000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	235000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	165000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P22Y10M24D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0683
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	222000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	371000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	50000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	50000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	8000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	701000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	50000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	651000	usd
CY2023Q2	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	1000000	usd
	wdq	Proceeds From Social Security Tax Employer Deferral Cares Act ProceedsFromSocialSecurityTaxEmployerDeferralCARESAct	2000000	usd
	wdq	Operating Expenses Offset Social Security Tax Employer Deferral Cares Act OperatingExpensesOffsetSocialSecurityTaxEmployerDeferralCARESAct	600000	usd
CY2023Q2	wdq	Social Security Tax Employer Deferral Cares Act SocialSecurityTaxEmployerDeferralCARESAct	1400000	usd
CY2023Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	427000	usd
CY2022Q2	wdq	Preferred Stock Convertible Conversion Trigger Amount Of Initial Public Offering PreferredStockConvertibleConversionTriggerAmountOfInitialPublicOffering	50000000	usd
CY2022Q2	wdq	Preferred Stock Convertible Conversion Trigger Percent Of Total Votes PreferredStockConvertibleConversionTriggerPercentOfTotalVotes	0.63
CY2022Q2	us-gaap	Preferred Stock Convertible Conversion Ratio PreferredStockConvertibleConversionRatio	1
CY2022Q2	wdq	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	0.59289
CY2022Q2	wdq	Sponsor Escrow Agreement Sponsor Earnout Shares SponsorEscrowAgreementSponsorEarnoutShares	1000000	shares
CY2022Q2	wdq	Sponsor Escrow Agreement Release Of Shares Stock Price Trigger SponsorEscrowAgreementReleaseOfSharesStockPriceTrigger	12.00
CY2022Q2	wdq	Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Days SponsorEscrowAgreementStockPriceTriggerThresholdTradingDays	20	day
CY2022Q2	wdq	Sponsor Escrow Agreement Stock Price Trigger Threshold Trading Day Period SponsorEscrowAgreementStockPriceTriggerThresholdTradingDayPeriod	30	day
CY2022Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41402847	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41402847	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	17884588	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	17884588	shares
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2028000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2610000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4290000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-5476000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31489803	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31489803	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19285050	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19285050	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29159766	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29159766	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18586515	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18586515	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18586515	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18586515	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2023Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	131000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	289000	usd
CY2022Q2	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	68000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	117000	usd

Files In Submission

Name	View Source	Status
0001628280-23-028887-index-headers.html	Edgar Link	pending
0001628280-23-028887-index.html	Edgar Link	pending
0001628280-23-028887.txt	Edgar Link	pending
0001628280-23-028887-xbrl.zip	Edgar Link	pending
exhibit321ceo906certificat.htm	Edgar Link	pending
exhibit322cfo906certificat.htm	Edgar Link	pending
exhibit331-ceo302certifica.htm	Edgar Link	pending
exhibit332-cfo302certifica.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
wdq-20230630.htm	Edgar Link	pending
wdq-20230630.xsd	Edgar Link	pending
wdq-20230630_def.xml	Edgar Link	unprocessable
wdq-20230630_lab.xml	Edgar Link	unprocessable
wdq-20230630_htm.xml	Edgar Link	completed
wdq-20230630_pre.xml	Edgar Link	unprocessable
wdq-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBIG
springbig Holdings Inc Stock $sbig

2023 Q2 Form 10-Q Financial Statement

#000162828023028887 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBIG springbig Holdings Inc Stock $sbig

2023 Q2 Form 10-Q Financial Statement

#000162828023028887 Filed on August 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBIG
springbig Holdings Inc Stock $sbig